Phenylephrine is an alpha-1 adrenergic receptor agonist used to treat hypotension, dilate the pupil, and induce local vasoconstriction. The action of phenylephrine, or neo-synephrine, was first described in literature in the 1930s.
Phenylephrine was granted FDA approval in 1939.
Phenylephrine is available in various drug formulations, which have different indications. Phenylephrine injections are indicated to treat hypotension caused by shock or anesthesia. The ophthalmic formulation is indicated to induce mydriasis and conjunctival vasoconstriction. The intranasal formulation is used to treat congestion, and a topical formulation ...
Centre of Postgraduate Medical Education,Department of Anesthesia and Intensive Care, Warsaw, Poland
Catharina hospital, Eindhoven, Noord-Brabant, Netherlands
Mount Sinai Hospital, Toronto, Ontario, Canada
maha sadek El Derh, Cairo, Heliopolis, Egypt
General hospital of Ningxia University, Yinchuan, Ningxia, China
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.